Interagency Guidelines; Medicines and medical devices for 10 000 people for approximately three month.
These standards for the quality of paediatric care in health facilities form part of normative
guidance for improving the quality of maternal, newborn, child and adolescent health care.
In view of the importance of the continuum of both the life-course and service delivery (1),
these standards bu...ild on the Standards for improving the quality of maternal and newborn
care in health facilities (2), during labour, childbirth and the early postnatal period.
more
Le Plan National de Développement Sanitaire (PNDS) est la traduction de la Politique nationale en matière de santé. Le présent PNDS 2018-2022est fondéentre autres surle Plan National de Développement (PND), le Plan de Croissance pour le Développement Durable (PC2D), la politique du Secteur de... la Santé,les Objectifs deDéveloppement Durable, les conclusions et recommandations de l’évaluation à mi-parcours du PNDS2009-2018, le PAG 2016-2021 et le rapport de la Commission Techniquechargée des Reformes du secteur de la Santé (CTRSS
more
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...am-negative bacteria, such as Klebsiella pneumoniae and Escherichia coli, can cause severe and often deadly infections that pose a particular threat for people with weak or not yet fully developed immune systems, including newborns, ageing populations, people undergoing surgery and cancer treatment.
The report highlights a worrying gap in activity against the highly resistant NDM-1 (New Delhi metallo-beta-lactamase 1), with only three antibiotics in the pipeline. NDM-1 makes bacteria resistant to a broad range of antibiotics, including those from the carbapenem family, which today are the last line of defence against antibiotic-resistant bacterial infections.
more
Le présent document donne des indications supplémentaires pour un usage responsable et prudent des
antimicrobiens chez les animaux élevés pour l’alimentation humaine. II convient de le lire en conjonction
avec le Code d’usages international recommandé pour le contrôle de l'utilisation de...s médicaments
vétérinaires (CAC/RCP 38-1993). Les objectifs visés sont la réduction au minimum de l'incidence
potentiellement défavorable sur la santé publique de l'usage d'agents antimicrobiens chez les animaux
élevés pour l’alimentation humaine et, en particulier, du développement d'une résistance aux antimicrobiens. II importe également d'assurer l'usage sûr et utile des médicaments vétérinaires antimicrobiens en médecine vétérinaire en en maintenant l'efficacité
more
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...of Essential Medicines (Model List). WHO is committed to supporting Member States in sharing best practices in selecting
essential medicines, and in developing processes for the selection of medicines for national essential medicines lists (national EMLs, or NEMLs) consistent with the evidence-based methods used for updating the WHO Model List.
more
A Students' Toolkit.
How does the digital transformation of health care change the daily routine of a healthcare professional? Which knowledge and skills will healthcare professionals need? Are universities in Europe preparing their students well enough to work within a digitised health system?
Th...is toolkit prepared by the European Medical Students’ Association (EMSA) provides an insightful context, an introduction to the topic of digital health and a framework to encourage future healthcare professionals to start activities and discussions at their university.
more
Ce rapport présente les résultats clés de la cinquième Enquête Démographique et de Santé du Cameroun
(EDSC-V) réalisée sur le terrain du 16 juin 2018 au 19 janvier 2019, par l’Institut National de la Statistique
(INS), en étroite collaboration avec le Ministère de la Santé Publique. ...L’enquête a été financée par le
Gouvernement camerounais, l’Agence des États-Unis pour le Développement International (USAID), le Fonds
des Nations Unies pour la Population (UNFPA) et le Fonds Mondial à travers le Programme National de Lutte
contre le Paludisme (PNLP). D’autres institutions ont également apporté leur expertise à la réalisation de cette
opération. Parmi elles figurent le Centre Pasteur du Cameroun (CPC) pour l’analyse des prélèvements sanguins
afin d’estimer la prévalence du VIH, et le Centre International de Référence Chantal Biya (CIRCB) pour le
contrôle de qualité externe des tests du VIH. ICF a fourni l’assistance technique à l’ensemble du projet par le
biais du Programme Mondial des Enquêtes Démographiques et de Santé, The DHS Program, financé par
l’USAID, et dont l’objectif est de fournir un soutien et une assistance technique aux pays du monde entier pour
la réalisation des enquêtes sur la population et la santé.
more
IBOGA Review No.1 Revue Scientifique du Jésuites d'Afrique de l'Ouest
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
This document focus on the direct consequences of the virus (morbidity and mortality) in specific populations and on the results of measures aimed at mitigating the spread of the virus, with indirect impacts on socio-economic conditions. In this complex scenario, the gender approach has not received... due attention during the pandemic. Gender is one of the structural determinants of health, but it does not appear in analyses of the direct and indirect effects of the pandemic, despite being essential in the recognition and analysis of the differential impacts on men and women and their interaction with the different determinants of health.
more
Glob Heart . 2020 Oct 13;15(1):69. doi: 10.5334/gh.891.
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...ey solutions on the road to equitable access to diagnostics and therapeutics.
This report draws from experience gained through the Access to COVID-19 Tools (ACT) Accelerator Diagnostics and Therapeutics pillars, and includes the perspectives of collaborating stakeholders (countries, civil society representatives and the private sector). Building on these findings, this report proposes sixteen recommended actions to address what have been identified as key structural challenges and specifies a potential owner for each action.
more